142 related articles for article (PubMed ID: 22578745)
1. Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia/lymphoma.
Vagace JM; de la Maya MD; Caceres-Marzal C; Gonzalez de Murillo S; Gervasini G
Crit Rev Oncol Hematol; 2012 Nov; 84(2):274-86. PubMed ID: 22578745
[TBL] [Abstract][Full Text] [Related]
2. [Complications in the central nervous system during chemotherapy for childhood acute lymphoblastic leukemia: JACLS ALL-02 study].
Umeda K; Yoshida M; Suzuki N; Endo M; Sato A; Hori H; Isogai M; Matsumoto K; Hara JI; Hasegawa D; Hashii Y; Chayama K; Miyaji R; Nishimura S; Tanizawa A; Uami I; Horibe K; Wakazono Y; Yagi K
Rinsho Ketsueki; 2007 Mar; 48(3):204-11. PubMed ID: 17441477
[TBL] [Abstract][Full Text] [Related]
3. [Neurotoxic the effects of chemotherapy on the function of the central nervous system in children with lymphoid tumors].
Kuznetsova EI
Patol Fiziol Eksp Ter; 2014; (4):71-7. PubMed ID: 25980230
[TBL] [Abstract][Full Text] [Related]
4. Cryptosporidiosis in children with acute lymphoblastic leukemia on maintenance chemotherapy.
Domenech C; Rabodonirina M; Bleyzac N; Pagès MP; Bertrand Y
J Pediatr Hematol Oncol; 2011 Oct; 33(7):570-2. PubMed ID: 21941152
[TBL] [Abstract][Full Text] [Related]
5. [Problems and therapy of acute lymphoblastic leukemia in children].
Matsuzaki A
Fukuoka Igaku Zasshi; 2000 Apr; 91(4):93-9. PubMed ID: 10917759
[No Abstract] [Full Text] [Related]
6. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.
Schmiegelow K; Forestier E; Hellebostad M; Heyman M; Kristinsson J; Söderhäll S; Taskinen M;
Leukemia; 2010 Feb; 24(2):345-54. PubMed ID: 20010622
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
[TBL] [Abstract][Full Text] [Related]
9. Therapy for childhood acute lymphoblastic leukemia.
Cassano WF; Eskenazi AE; Frantz CN
Curr Opin Oncol; 1993 Jan; 5(1):42-52. PubMed ID: 8427893
[TBL] [Abstract][Full Text] [Related]
10. [Lymphoblastic lymphoma in children. Poor response in advanced disease with chemotherapy for non-Hodgkin's lymphoma].
Rivera-Luna R; Cárdenas-Cardós R; Martínez-Avalos A; Leal-Leal C; Ruano-Aguilar J; Meza-Coria C; Lanche-Guevara T; de León-Bojorge B
Rev Invest Clin; 1994; 46(5):369-75. PubMed ID: 7839017
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
13. Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response.
Marino S; Verzegnassi F; Tamaro P; Stocco G; Bartoli F; Decorti G; Rabusin M
Pediatr Blood Cancer; 2009 Dec; 53(6):984-91. PubMed ID: 19621425
[TBL] [Abstract][Full Text] [Related]
14. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia.
Cole PD; Kamen BA
Ment Retard Dev Disabil Res Rev; 2006; 12(3):174-83. PubMed ID: 17061283
[TBL] [Abstract][Full Text] [Related]
15. [High methotrexate doses in the treatment program for acute lymphoblastic leukemia and lymphosarcoma in children].
Makhonova LA; Maiakova SA; Kiselev AV; Gordina GA; Balakirev SA; Gavrilova IE; Moiseenko EI; Morozova OV
Vopr Onkol; 1990; 36(10):1196-200. PubMed ID: 2251813
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy vs intrathecal chemotherapy for CNS prophylaxis in childhood ALL.
Steinherz PG
Oncology (Williston Park); 1989 Sep; 3(9):47-53; discussion 58-60. PubMed ID: 2701698
[TBL] [Abstract][Full Text] [Related]
17. [Neurologic complications during chemotherapy of children with acute lymphoid leukemia].
Kardos M; Grexa E; Kajtár P
Orv Hetil; 1992 May; 133(18):1111-5. PubMed ID: 1579351
[TBL] [Abstract][Full Text] [Related]
18. Acute Central Nervous System Complications in Pediatric Acute Lymphoblastic Leukemia.
Baytan B; Evim MS; Güler S; Güneş AM; Okan M
Pediatr Neurol; 2015 Oct; 53(4):312-8. PubMed ID: 26202590
[TBL] [Abstract][Full Text] [Related]
19. No role for cerebrospinal fluid myelin basic protein levels in patients treated for childhood acute lymphoblastic leukemia.
Diezi M; Garcia E; Weid Nv; Beck-Popovic M
J Pediatr Hematol Oncol; 2009 Jun; 31(6):393-7. PubMed ID: 19648787
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics of pediatric acute lymphoblastic leukemia.
Meeker ND; Yang JJ; Schiffman JD
Expert Opin Pharmacother; 2010 Jul; 11(10):1621-32. PubMed ID: 20429672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
